89bio Announces Proposed Public Offering of Common Stock by Seini Moimoi | Jul 6, 2020 | Portfolio News
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by Seini Moimoi | Jul 2, 2020 | Portfolio News
Axonics® Receives FDA Approval for 3T Full-Body MRI Scans by Seini Moimoi | Jul 1, 2020 | Portfolio News
WEP Clinical Partners With Nabriva Therapeutics For The Named Patient Supply Of Xenleta® (Lefamulin) by Seini Moimoi | Jun 30, 2020 | Portfolio News
Akebia Therapeutics Announces Approval of Vadadustat in Japan for the Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-Dependent and Non-Dialysis Dependent Adult Patients by Seini Moimoi | Jun 29, 2020 | Portfolio News
